Your new experience awaits. Try the new design now and help us make it even better

REVIEW article

Front. Cell Dev. Biol.

Sec. Cancer Cell Biology

Volume 13 - 2025 | doi: 10.3389/fcell.2025.1555687

Recent Advances in Aptamer-Based Biosensing Technology for Isolation and Detection of Extracellular Vesicles

Provisionally accepted
Osama  Alnaser-AlmusaOsama Alnaser-Almusa1Mohammed  MahmoudMohammed Mahmoud1Mohammed  IlyasMohammed Ilyas1Raghda  AdwanRaghda Adwan1Farah  Abul RubFarah Abul Rub1Noha  Alnaser-AlmusaNoha Alnaser-Almusa1Fayrouz  MustafaFayrouz Mustafa1Sana  AhmedSana Ahmed2Alaa  AlzhraniAlaa Alzhrani3Tanveer  Ahmad MirTanveer Ahmad Mir2Mubarak.  AlabudahashMubarak. Alabudahash4Raja  ChinnappanRaja Chinnappan1*Ahmed  YaqinuddinAhmed Yaqinuddin1
  • 1Alfaisal University, Riyadh, Saudi Arabia
  • 2King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia
  • 3King Abdulaziz University, Jeddah, Makkah, Saudi Arabia
  • 4Strathclyde Institute of Pharmacy and Biomedical Sciences, Faculty of Science, University of Strathclyde, Glasgow, Scotland, United Kingdom

The final, formatted version of the article will be published soon.

Since their discovery in the 1970s, extracellular vesicles (EVs) have garnered significant scientific attention due to their involvement in diverse pathological processes, including tumorigenesis.Their unique properties have also piqued interest for various applications such as transporting biomolecules for drug delivery. Researchers have developed numerous isolation and detection methods for EVs, including ultracentrifugation, immunoaffinity capture, and antibody-based biosensors. However, these techniques often suffer from limitations in sensitivity, specificity, and efficiency, hindering their performance and reliability in research and clinical settings. Aptamers are short, single-stranded DNA or RNA molecules created to selectively bind to a specific target and offer a promising alternative to antibodies. These aptamers are identified by a process known as SELEX. By repeatedly selecting and amplifying aptamers with high binding affinity, SELEX can generate aptamers with exceptional specificity and sensitivity. Aptamers can then be incorporated into biosensors, known as aptasensors, for EV isolation, detection, and analysis.Aptasensors offer several advantages over antibody-based methods. They are often more stable, can be produced synthetically at lower cost, and can be easily modified for various applications.Additionally, aptamers can be selected against a wide range of targets, including proteins, nucleic acids, and small molecules, making them versatile tools for EV research. This review discusses various SELEX methods for aptamer detection, the clinical uses of aptamers, and the types of EV analysis methods.

Keywords: Aptasensors, aptamers, extracellular vesicles, Exosomes, SELEX, EVs Isolation and Detection Font color: Red, Not Highlight Font color: Red, Not Highlight Font: Bold

Received: 05 Jan 2025; Accepted: 09 Jul 2025.

Copyright: © 2025 Alnaser-Almusa, Mahmoud, Ilyas, Adwan, Abul Rub, Alnaser-Almusa, Mustafa, Ahmed, Alzhrani, Mir, Alabudahash, Chinnappan and Yaqinuddin. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Raja Chinnappan, Alfaisal University, Riyadh, Saudi Arabia

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.